CDD, St. Jude Alliance Aims to Quicken Rx Development for Resistant Malaria | GenomeWeb
NEW YORK (GenomeWeb News) — Collaborative Drug Discovery and St. Jude Children's Research Hospital have penned an alliance to speed the development of drugs to treat resistant strains of malaria.
 
The collaboration is designed to help scientists quickly screen millions of chemicals, based on their structure and their chemical and biological properties, to find those that are most likely to make effective anti-malaria drugs.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.